|
|
|
Insider
Information: |
Sonsini Peter W. |
Relationship: |
10% Owner |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
39 |
|
Direct
Shares |
66,219,175 |
|
Indirect Shares
|
287,129,918 |
|
|
Direct
Value |
$484,917,870 |
|
|
Indirect Value
|
$554,586,967 |
|
|
Total
Shares |
353,349,093 |
|
|
Total
Value |
$1,039,504,837 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
21.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
24 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
745 |
2020-09-14 |
596 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2020-05-20 |
2,892,877 |
2018-04-23 |
3,312,877 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
339 |
2018-02-13 |
676 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
821 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
54 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2021-03-15 |
24,137,931 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Reneo Pharmaceuticals, Inc. |
RPHM |
10% Owner |
2021-04-13 |
4,785,494 |
2021-04-13 |
0 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-02 |
270 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-05-31 |
26,306,693 |
2022-11-16 |
70 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2022-01-25 |
3,305,601 |
2021-12-27 |
0 |
Premium* |
|
Casper Sleep Inc. |
CSPR |
10% Owner |
2022-01-25 |
0 |
2022-01-25 |
0 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-02-08 |
6,432,762 |
2022-12-20 |
12 |
Premium* |
|
Senti Biosciences, Inc |
SNTI |
10% Owner |
2022-06-08 |
4,426,151 |
|
0 |
Premium* |
|
Zerofox Holdings Ord Shs |
ZFOX |
10% Owner |
2022-08-03 |
18,068,513 |
|
0 |
Premium* |
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
2023-01-03 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-06 |
4 |
B |
$1.99 |
$54,414 |
I/I |
27,300 |
20,191,738 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-07 |
4 |
B |
$1.98 |
$232,362 |
I/I |
117,100 |
20,308,838 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-10 |
4 |
B |
$1.98 |
$51,576 |
I/I |
26,000 |
20,334,838 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-11 |
4 |
B |
$1.98 |
$121,084 |
I/I |
61,200 |
20,396,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-20 |
4 |
B |
$1.63 |
$326,060 |
I/I |
200,000 |
20,596,038 |
1.5 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2018-12-21 |
4 |
B |
$1.49 |
$448,380 |
I/I |
300,000 |
20,896,038 |
1.5 |
- |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
133,640,415 |
22,288,629 |
0 |
- |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-28 |
4 |
B |
$18.00 |
$34,999,992 |
I/I |
1,944,444 |
23,983,073 |
1.5 |
% |
|
SVRA |
Savara Inc |
10% Owner |
|
2021-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,137,931 |
|
% |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2019-04-08 |
4 |
B |
$1.14 |
$4,956,523 |
I/I |
4,347,827 |
25,243,865 |
1.5 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-05-31 |
4 |
S |
$5.65 |
$2,815,374 |
D/D |
(498,614) |
26,306,693 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-05-27 |
4 |
S |
$5.93 |
$8,880,359 |
D/D |
(1,497,733) |
26,805,307 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-05-26 |
4 |
S |
$5.80 |
$5,377,726 |
D/D |
(926,619) |
28,303,040 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2020-12-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,398,927 |
|
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2021-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,229,659 |
|
% |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
ILIU |
Interleukin Genetics Inc |
10% Owner |
|
2014-12-23 |
4 |
B |
$0.10 |
$1,992,857 |
I/I |
19,868,965 |
35,298,087 |
1.5 |
- |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
46,859,421 |
|
- |
|
ILIU |
Interleukin Genetics Inc |
10% Owner |
|
2016-07-29 |
4 |
B |
$0.10 |
$2,000,000 |
I/I |
20,120,724 |
55,418,811 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
59,269,000 |
|
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2017-03-27 |
4 |
B |
$0.70 |
$9,009,000 |
I/I |
12,870,000 |
72,139,000 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-21 |
4 |
B |
$1.81 |
$189,820 |
I/I |
104,844 |
72,243,844 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-22 |
4 |
B |
$1.90 |
$1,655,669 |
I/I |
869,574 |
73,113,418 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-23 |
4 |
B |
$1.95 |
$572,358 |
I/I |
294,090 |
73,407,508 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
|
2018-03-26 |
4 |
B |
$1.90 |
$1,087,553 |
I/I |
571,164 |
73,978,672 |
1.5 |
- |
|
176 Records found
|
|
Page 7 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|